These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7000339)

  • 1. Effect of feeder cell-released substances on the survival of clonogenic 9L cells after treatment with antimetabolites.
    Weizsaecker M; Deen DF
    Cancer Res; 1980 Sep; 40(9):3202-5. PubMed ID: 7000339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokinetic and cytotoxic effects of antimetabolites on 9L rat brain tumor cells in vitro.
    Weizsaecker M; Hoshino T; Deen DF; Kobayashi S
    Cancer Res; 1981 Oct; 41(10):3835-9. PubMed ID: 7284990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assays using undialyzed fetal bovine serum.
    Sobrero AF; Bertino JR
    Int J Cell Cloning; 1986 Jan; 4(1):51-62. PubMed ID: 2936838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents].
    Jeremić B; Sibamoto J; Abe M
    Srp Arh Celok Lek; 1996; 124(7-8):169-74. PubMed ID: 9102841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of anticancer drugs on multicellular spheroid of 9L rat brain tumor].
    Kohno T; Matsutani M; Hoshino T; Takakura K
    No To Shinkei; 1985 Oct; 37(10):991-7. PubMed ID: 3865669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal deoxyuridine suppression as a rapid predictor for antimetabolite chemosensitivity: correlation with in vitro tests of growth inhibition.
    Block JB; Chlebowski RT; Dietrich MF; Isacoff WH
    Cancer Treat Rep; 1984 Apr; 68(4):631-6. PubMed ID: 6538809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in susceptibility to cytotoxic antibody among tumor cells surviving exposure to chemotherapeutic agents.
    Shapiro SJ; Leibson PJ; Loken MR; Schreiber H
    Cancer Res; 1982 Jul; 42(7):2622-7. PubMed ID: 7083155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined cytotoxic effect of low-dose 5-fluorouracil and hydroxyurea on 9L cells in vitro.
    Kobayashi S; Hoshino T
    Cancer Res; 1983 Nov; 43(11):5309-13. PubMed ID: 6616466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum factors that suppress cytotoxic effect of methotrexate.
    Kojima T; Hashimoto Y; Inamura Y; Koide T; Nagata H; Ito N; Suzumura K
    Exp Oncol; 2009 Dec; 31(4):209-13. PubMed ID: 20010533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer drugs: effect on the cloning of Raji lymphoma cells in soft agar.
    Wu PC; Ozols RF; Hatanaka M; Boone CW
    J Natl Cancer Inst; 1982 Jan; 68(1):115-21. PubMed ID: 6948121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical behavior of 6-mercaptopurine as a cytotoxic agent: decreasing cell kill with increasing drug dose.
    Matsumura S; Hoshino T; Weizsaecker M; Deen DF
    Cancer Treat Rep; 1983 May; 67(5):475-80. PubMed ID: 6682702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
    Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
    Cole PD; Smith AK; Kamen BA
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):111-6. PubMed ID: 12172974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of 9L tumor cells in vitro to spirohydantoin mustard.
    Deen DF; Hoshino T; Williams ME; Nomura K; Bartle PM
    Cancer Res; 1979 Nov; 39(11):4336-40. PubMed ID: 498067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized methods to bioassay neurotrophic factors for dopaminergic neurons.
    Takeshima T; Shimoda K; Johnston JM; Commissiong JW
    J Neurosci Methods; 1996 Jul; 67(1):27-41. PubMed ID: 8844522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repair of potentially lethal damage in unfed plateau phase cultures of Ehrlich ascites tumour cells. II. Monolayer cultures.
    Iliakis G
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Jun; 37(6):591-600. PubMed ID: 6998889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors modifying cytotoxicity induced by 5-FU and hydroxyurea.
    Hoshino T; Nagashima T
    Cancer Treat Rep; 1985 Sep; 69(9):993-7. PubMed ID: 4028040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 5-fluorouracil on the release of thymidine kinase from hepatoma cells in vitro.
    Taylor A; Jones OW; Grishaver MA
    Cancer Res; 1981 Jan; 41(1):192-6. PubMed ID: 7448759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.